An international team of scientists have designed a new generation of universal flu vaccines to protect against future global pandemics that could kill millions.
The vaccine could give protection for up to 88% of known flu strains worldwide in a single shot, spelling the end of the winter flu season. The collaboration involving the universities of Lancaster, Aston and Complutense in Madrid have applied ground-breaking computational techniques to design the vaccine in a study published in the leading journal Bioinformatics.
The researchers have devised two universal vaccines;
- a USA-specific vaccine with coverage of 95% of known US influenza strains
- a universal vaccine with coverage of 88% of known flu strains globally
Dr Derek Gatherer of Lancaster University said: “Every year we have a round of flu vaccination, where we choose a recent strain of flu as the vaccine, hoping that it will protect against next year’s strains. We know this method is safe, and that it works reasonably well most of the time.
“However, sometimes it doesn’t work – as in the H3N2 vaccine failure in winter 2014-2015 – and even when it does it is immensely expensive and labour-intensive. Also, these yearly vaccines give us no protection at all against potential future pandemic flu.” Previous pandemics include the “Spanish flu” of 1918, and the two subsequent pandemics of 1957 and 1968, which led to millions of deaths.
Even today, the World Health Organisation says that annual flu epidemics are estimated to cause up to half a million deaths globally. Dr Gatherer said: “It doesn’t have to be this way. Based on our knowledge of the flu virus and the human immune system, we can use computers to design the components of a vaccine that gives much broader and longer-lasting protection.”
Dr Pedro Reche of Complutense University said: “A universal flu vaccine is potentially within reach. The components of this vaccine would be short flu virus fragments – called epitopes – that are already known to be recognized by the immune system. Our collaboration has found a way to select epitopes reaching full population coverage.
Dr Darren Flower of Aston University said: “Epitope-based vaccines aren’t new, but most reports have no experimental validation. We have turned the problem on its head and only use previously-tested epitopes. This allows us to get the best of both worlds, designing a vaccine with a very high likelihood of success.”
The team are now actively seeking partners in the pharmaceutical industry to synthesize their vaccine for a laboratory proof-of-principle test.
Learn more: Universal flu vaccine designed by scientists
The Latest on: Universal flu vaccine
via Google News
The Latest on: Universal flu vaccine
- Universal one-shot flu vaccine could soon eradicate the disease forever on February 18, 2019 at 3:22 pm
Tired of seasonal flu shots that don't always work? Researchers in Australia might have just discovered the flu shot to end all flu shots-- and possibly, end influenza too, reports MedicalXpress.com. ... […]
- Our ‘killer’ cells’ role in life-long flu vaccine on February 18, 2019 at 3:19 pm
The team has a patent on the discoveries, which means they can develop a universal influenza vaccine approach to reduce the impact of pandemic and seasonal influenza around the world. Influenza sample... […]
- Universal flu vaccine hope as scientists find immune cells which fight all strains on February 18, 2019 at 11:21 am
Immune cells which could fight all kinds of influenza virus have been discovered by scientists, raising hope for a universal vaccine which does not need to be update annually. Researchers from the Pet... […]
- 'Killer' cells raise hope of universal flu vaccine on February 18, 2019 at 11:08 am
Scientists said Monday they had discovered immune cells that can fight all known flu viruses in what was hailed as an "extraordinary breakthrough" that could lead to a universal, one-shot vaccine agai... […]
- Universal flu vaccine a big step closer - but it will only help half of us on February 18, 2019 at 8:01 am
A huge taskforce of Australian research institutions believe they have taken major steps towards developing a universal flu vaccine that could last for up to 10 years. They have found a part of the fl... […]
- FluGen pushes forward with development of 'universal' flu vaccine after phase 2 win on February 15, 2019 at 10:24 am
Biopharma companies big and small are seeking to advance flu vaccine research as recent seasons have underscored issues with traditional vaccines. Now, FluGen reports its intranasal vaccine succeeded ... […]
- FluGen’s vaccine proves effective in human challenge trial on February 12, 2019 at 4:51 pm
The company has been working to develop a universal flu vaccine that can protect against strains of the virus that have drifted significantly from the strains included in traditional vaccines. The hop... […]
- FluGen’s M2SR Influenza Vaccine Succeeds in Phase 2 Human Challenge Trial Against a Highly Mismatched Virus on February 12, 2019 at 4:01 am
This major step toward demonstrating breadth of protection is key to developing a universal flu vaccine against flu viruses that have significantly drifted from the strains contained in the vaccines. ... […]
- Oxford signs deal with US startup to develop universal flu vaccine on February 10, 2019 at 8:31 am
The University of Oxford announced that it has signed a deal to develop a universal influenza vaccine candidate with Blue Water Vaccines, a United States-based startup. The technology developed by the ... […]
via Bing News